T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Rambus
RMBS
$10.8B
| $795K | ﹤0.01% |
57,800
| – | – |
|
1777
Neogen
NEOG
$2.59B
| $793K | ﹤0.01% |
42,000
+6,667
| +19% | +$127K |
|
|
PKY
1778
DELISTED
Parkway, Inc.
PKY
| $793K | ﹤0.01% |
50,653
+9,700
| +24% | +$135K |
|
|
TCF
1779
DELISTED
TCF Financial Corporation Common Stock
TCF
| $791K | ﹤0.01% |
22,151
+500
| +2% | +$16.7K |
|
1780
Horace Mann Educators
HMN
$2.1B
| $789K | ﹤0.01% |
24,910
+1,290
| +5% | +$39.6K |
|
|
HW
1781
DELISTED
Headwaters Inc
HW
| $788K | ﹤0.01% |
39,700
| – | – |
|
1782
Molina Healthcare
MOH
$10.7B
| $786K | ﹤0.01% |
12,194
+3,300
| +37% | +$196K |
|
1783
Sturm, Ruger & Co
RGR
$601M
| $783K | ﹤0.01% |
11,450
+4,700
| +70% | +$306K |
|
1784
Huntsman Corp
HUN
$1.81B
| $782K | ﹤0.01% |
58,821
+6,600
| +13% | +$68.2K |
|
1785
Insight Enterprises
NSIT
$4.6B
| $780K | ﹤0.01% |
27,250
+3,200
| +13% | +$80.6K |
|
|
SVU
1786
DELISTED
SUPERVALU Inc.
SVU
| $780K | ﹤0.01% |
19,356
-943
| -5% | -$33.6K |
|
1787
New York Times
NYT
$10.3B
| $779K | ﹤0.01% |
62,500
+6,000
| +11% | +$76K |
|
|
HRC
1788
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $775K | ﹤0.01% |
15,417
+650
| +4% | +$30.7K |
|
1789
Boot Barn
BOOT
$4.92B
| $771K | ﹤0.01% |
82,070
-41,320
| -33% | -$369K |
|
|
CIM
1790
Chimera Investment
CIM
$993M
| $765K | ﹤0.01% |
18,767
| – | – |
|
1791
Community Health Systems
CYH
$419M
| $764K | ﹤0.01% |
49,929
-341,159
| -87% | -$5.21M |
|
1792
H.B. Fuller
FUL
$3.24B
| $764K | ﹤0.01% |
17,990
+3,020
| +20% | +$113K |
|
|
ASCMA
1793
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $764K | ﹤0.01% |
51,555
+21,700
| +73% | +$274K |
|
|
AL
1794
DELISTED
Air Lease Corp
AL
| $762K | ﹤0.01% |
23,713
+8
| +0% | +$227 |
|
1795
iShares MSCI Japan ETF
EWJ
$23.2B
| $760K | ﹤0.01% |
16,650
+8,300
| +99% | +$373K |
|
|
S
1796
DELISTED
Sprint Corporation
S
| $759K | ﹤0.01% |
218,160
+120,800
| +124% | +$386K |
|
1797
GATX Corp
GATX
$6.33B
| $757K | ﹤0.01% |
15,938
| – | – |
|
|
CXP
1798
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $753K | ﹤0.01% |
34,263
+6,710
| +24% | +$145K |
|
|
DF
1799
DELISTED
Dean Foods Company
DF
| $753K | ﹤0.01% |
43,490
-392,438
| -90% | -$7.42M |
|
1800
Acco Brands
ACCO
$399M
| $750K | ﹤0.01% |
83,497
+930
| +1% | +$6.5K |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.